is a topic covered in the Johns Hopkins HIV Guide
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
- Treatment of HIV infection in combination with other antiretroviral agents.
- Due to increased risk of hepatitis, avoid starting NVP in women with pre-treatment CD4 >250 and men with CD4 >400.
- Single dose at time of delivery to prevent perinatal transmission (widely used in developing countries, but risk of NNRTI resistance; combination therapy preferred when available). Risk of hepatitis for women with CD4 >250 does not apply to single dose NVP.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: June 27, 2014
Pham, Paul A, et al. "Nevirapine." Johns Hopkins HIV Guide, 2014. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545148/10/Nevirapine.
Pham PA, Bartlett JG, Hsu A . Nevirapine. Johns Hopkins HIV Guide. 2014. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545148/10/Nevirapine. Accessed October 13, 2019.
Pham, P. A., Bartlett, J. G., & Hsu, A. . (2014). Nevirapine. In Johns Hopkins HIV Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545148/10/Nevirapine
Pham PA, Bartlett JG, Hsu A . Nevirapine [Internet]. In: Johns Hopkins HIV Guide. ; 2014. [cited 2019 October 13]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545148/10/Nevirapine.
TY - ELEC
T1 - Nevirapine
ID - 545148
A1 - Pham,Paul,Pharm.D.
AU - Bartlett,John,M.D.
AU - Hsu,Alice,Pharm.D.
Y1 - 2014/06/27/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545148/10/Nevirapine
DB - Johns Hopkins Guide
DP - Unbound Medicine